98%
921
2 minutes
20
Purpose: The aim of this study was to analyze the surgical outcomes of endoscopic tympanoplasty (ET) type I, and to investigate the learning curve of ET type I in a surgeon experienced in microscopic surgery.
Methods: We retrospectively studied patients with tympanic membrane perforations who had undergone ET type I from January 2015 to June 2020. All procedures were performed by a single senior surgeon with considerable microscopic experience. We compared the perforation closure rate in relation to age, previous ear surgery history, graft material, size, and location of perforation. We compared the operation time according to the number of operated patients.
Results: A total of 399 patients were enrolled. The success rate of ET type I was 92.7%. Age, prior ear surgery, graft material, size, and location of perforation did not influence the surgical outcomes. The surgical time for the initial ten cases was the longest (78.3 min), and stabilized after the first 100 cases to under 60 min. The surgical success rate was 96.0% in the first 50 cases, and decreased to approximately 92% afterwards.
Conclusion: The surgical time largely decreased with the number of operated patients. Since the operations were performed by a surgeon experienced in microscopy, the success rate of initial cases was not low, even though the operation time of these initial cases was longer. We believe that endoscope provides a new perspective on ear surgery if it could overcome the difficulties in the early stage.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00405-021-07093-w | DOI Listing |
Foot Ankle Int
September 2025
Department of Orthopaedic Surgery, St. Luke's University Health Network, Bethlehem, PA, USA.
Background: In response to the opioid epidemic, many surgical specialties have adopted nonopioid pain management strategies. Ultrasound (US)-guided peripheral nerve blocks (PNBs) are effective in reducing pain and opioid consumption postsurgery. Liposomal bupivacaine (LB), shown effective in shoulder surgery, was approved in November 2023 for use in US-guided lower extremity blocks.
View Article and Find Full Text PDFOrthop Traumatol Surg Res
September 2025
Service de Chirurgie Orthopédique, CHRU de Tours, France - Faculté de Médecine, Université de Tours, France.
Purpose: The potential of mixed reality to improve the accuracy of glenoid preparation pin positioning in shoulder arthroplasty has been previously reported. Another benefit of mixed reality may be its ability to assist junior surgeons in enhancing their precision during prosthetic procedures. The aim of this study was to evaluate and compare the accuracy of glenoid preparation pin positioning between a senior surgeon and a junior surgeon utilizing mixed reality guidance.
View Article and Find Full Text PDFOphthalmol Glaucoma
September 2025
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, England; Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, New South Wales, Australia.
Purpose: To compare the long-term safety of MicroShunt implantation with trabeculectomy in eyes with primary open-angle glaucoma (POAG).
Methods: This was a 3-year observational extension of a 2-year prospective randomized trial comparing clinical outcomes of MicroShunt implantation with trabeculectomy, both augmented with mitomycin C. Adverse events (AEs), intraocular pressure (IOP), and IOP-lowering medication use were recorded 36, 48, and 60 months after initial randomization.
Surg Endosc
September 2025
The Griffin Institute, London, UK.
Background: Robotic surgery has witnessed rapid growth and development, with a concomitant training requirement. However, educational methods can vary, for example, industry or clinician led. This can result in heterogeneous training.
View Article and Find Full Text PDFCureus
August 2025
Surgery, Rocky Vista University College of Osteopathic Medicine, Ivins, USA.
Implant extrusion is a rare but serious complication typically linked to infection, poor wound healing, or material intolerance. This case report describes a 79-year-old female patient who experienced extrusion of both a hip prosthesis and an Inspire hypoglossal nerve stimulator (Inspire Medical Systems, Inc., Minnesota, USA), each event associated with the use of Ethibond (Ethicon, Johnson & Johnson, Georgia, USA) sutures.
View Article and Find Full Text PDF